US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

DAMORA THERAPEUT

20.65

+0.42002.08%

Post-market: 20.27-0.3849-1.86%19:50 EDT

Volume:692.89K

Turnover:13.99M

Market Cap:1.27B

PE:-2.09

High:20.77

Open:20.55

Low:19.59

Close:20.23

52wk High:38.33

52wk Low:3.50

Shares:61.55M

Float Shares:47.65M

Volume Ratio:1.07

T/O Rate:1.45%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-9.8764

EPS(LYR):-153.9532

ROE:-99.74%

ROA:-21.61%

PB:3.29

PE(LYR):-0.13

Loading ...

Overview Company News Filings

Damora Therapeutics Begins Trial of DMR-001 in ET, Myelofibrosis

MT Newswires Live

Damora Therapeutics Initiates Phase 1/1B Clarity-101 Clinical Trial of Dmr-001 in Patients with Mutant Calreticulin-Driven Essential Thrombocythemia and Myelofibrosis

THOMSON REUTERS

Damora Therapeutics - Expects Initial Clarity-101 Trial Data Beginning Mid-2027

THOMSON REUTERS

Damora Therapeutics Grants 451,000 Inducement Stock Options at $28.99 Per Share

Damora Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

THOMSON REUTERS

Damora Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

U.S. Research ROUNDUP-Blackstone, Hartford Insurance, Zevra Therapeutics

Damora Therapeutics Inc (pre-reincorporation) : Jefferies Initiates Coverage with Buy Rating; Price Target $50

THOMSON REUTERS

Damora Therapeutics initiated with a Buy at Jefferies

Damora Therapeutics Redomiciles from Delaware to Cayman Islands

Damora Therapeutics (DMRA) Joins Russell Indexes With Valuation Still Looking About Right

Simply Wall St.

Damora Therapeutics Grants Inducement Stock Options for 453,500 Shares at USD 26.01 Each

Damora Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Analysts Have Conflicting Sentiments on These Healthcare Companies: Damora Therapeutics (DMRA), Summit Therapeutics (SMMT) and Elicio Therapeutics (ELTX)

Damora Therapeutics shareholders elect Landsittel, Turtle to board

Analysts Offer Insights on Healthcare Companies: Phibro Animal Health (PAHC) and Damora Therapeutics (DMRA)

Damora Therapeutics publishes DMR-001 mutant calreticulin antibody presentation

Damora Therapeutics Inc : H.c. Wainwright Initiates Coverage With Buy Rating; Price Target $45

THOMSON REUTERS

U.S. RESEARCH ROUNDUP-Arthur J. Gallagher & Co, Datadog, Oracle

TD Cowen Initiates Damora Therapeutics at Buy

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://hk.tigershowtime.com/stock/DMRA/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"DMRA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"DMRA\",,,,,undefined,":{"symbol":"DMRA","market":"US","secType":"STK","nameCN":"DAMORA THERAPEUT","latestPrice":20.65,"timestamp":1790971200000,"preClose":20.23,"halted":0,"volume":692889,"hourTrading":{"tag":"盘后","latestPrice":20.2651,"preClose":20.65,"latestTime":"19:50 EDT","volume":6006,"amount":123920.9723,"timestamp":1790985052918,"change":-0.3849,"changeRate":-0.018639,"amplitude":0.018639},"delay":0,"changeRate":0.020761245674740393,"floatShares":47648701,"shares":61553200,"eps":-9.876431,"marketStatus":"Closed","change":0.42,"latestTime":"10-02 16:00:00 EDT","open":20.55,"high":20.765,"low":19.59,"amount":13986209.747706,"amplitude":0.058082,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-9.876431,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791187200000},"marketStatusCode":5,"adr":0,"listingDate":1603944000000,"exchange":"NASDAQ","adjPreClose":20.23,"postHourTrading":{"tag":"盘后","latestPrice":20.2651,"preClose":20.65,"latestTime":"19:50 EDT","volume":6006,"amount":123920.9723,"timestamp":1790985052918,"change":-0.3849,"changeRate":-0.018639,"amplitude":0.018639},"volumeRatio":1.068996},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"DMRA\",,,,,undefined,":{"symbol":"DMRA","floatShares":47648701,"roa":"-21.61%","roe":"-99.74%","lyrEps":-153.953213,"volumeRatio":1.068996,"shares":61553200,"dividePrice":0,"high":20.765,"amplitude":0.058082,"preClose":20.23,"low":19.59,"week52Low":3.5,"pbRate":"3.29","week52High":38.3251,"institutionHeld":0,"latestPrice":20.65,"eps":-9.876431,"divideRate":0,"volume":692889,"delay":0,"ttmEps":-9.876431,"open":20.55,"prevYearClose":23.01,"prevWeekClose":20.66,"prevMonthClose":21.28,"prevQuarterClose":21.28,"fiveDayClose":20.66,"twentyDayClose":28,"sixtyDayClose":30.78},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/DMRA\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-05-12","symbol":"DMRA","fiscalQuarterEnding":"2026/03","expectedEps":-0.21,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1778558400000,"reportTimeType":"post","actualEps":-0.62},{"market":"US","date":"2026-03-19","symbol":"DMRA","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1773892800000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2025-11-06","symbol":"DMRA","fiscalQuarterEnding":"2025/09","expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1762405200000,"reportTimeType":"post","actualEps":-2.36},{"market":"US","date":"2025-08-05","symbol":"DMRA","fiscalQuarterEnding":"2025/06","expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1754366400000,"reportTimeType":"post","actualEps":-2.6},{"market":"US","date":"2025-05-08","symbol":"DMRA","fiscalQuarterEnding":"2025/03","expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1746676800000,"reportTimeType":"post","actualEps":-1.92}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"DMRA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"DMRA\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.4,"buy":0.6,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6,"analysts":10,"updateTime":1785124800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/DMRA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"DMRA","date":"2026-10-01","current":-2.090836,"percent":0.964286,"low":-100.260711,"twenty":-7.670132,"median":-7.112617,"eighty":-6.008983,"high":-4.761245,"avg":-11.64812,"sd":19.89652,"marketCap":1313731844},"quantilePoints":[{"date":"2026-03-13","current":-100.260711,"twenty":-100.260711,"median":-100.260711,"eighty":-98.29884,"marketCap":1588530698},{"date":"2026-03-20","current":-72.999835,"twenty":-100.199878,"median":-95.983376,"eighty":-84.763454,"marketCap":1156609382},{"date":"2026-03-27","current":-7.36551,"twenty":-98.861547,"median":-80.41388,"eighty":-7.003988,"marketCap":1545571323},{"date":"2026-04-02","current":-7.207452,"twenty":-96.587906,"median":-7.443103,"eighty":-7.019507,"marketCap":1512404556},{"date":"2026-04-10","current":-7.670132,"twenty":-94.238224,"median":-7.361199,"eighty":-7.021806,"marketCap":1609492728},{"date":"2026-04-17","current":-7.759219,"twenty":-89.113027,"median":-7.443103,"eighty":-7.088477,"marketCap":1628186724},{"date":"2026-04-24","current":-7.305161,"twenty":-78.931071,"median":-7.519258,"eighty":-7.200555,"marketCap":1532907649},{"date":"2026-05-01","current":-7.374132,"twenty":-59.951712,"median":-7.420112,"eighty":-7.071235,"marketCap":1547380419},{"date":"2026-05-08","current":-7.181588,"twenty":-7.748873,"median":-7.369821,"eighty":-7.098823,"marketCap":1506977267},{"date":"2026-05-15","current":-6.125513,"twenty":-7.702318,"median":-7.328151,"eighty":-6.979849,"marketCap":1440040702},{"date":"2026-05-22","current":-6.376895,"twenty":-7.679328,"median":-7.296539,"eighty":-6.874668,"marketCap":1499137850},{"date":"2026-05-29","current":-6.50384,"twenty":-7.670132,"median":-7.208889,"eighty":-6.624282,"marketCap":1528981338},{"date":"2026-06-05","current":-5.841412,"twenty":-7.647141,"median":-7.181588,"eighty":-6.506459,"marketCap":1373251758},{"date":"2026-06-12","current":-5.592674,"twenty":-7.644267,"median":-7.103996,"eighty":-6.310202,"marketCap":1314776223},{"date":"2026-06-18","current":-5.608384,"twenty":-7.605184,"median":-7.036462,"eighty":-6.158347,"marketCap":1318469415},{"date":"2026-06-26","current":-5.909488,"twenty":-7.595413,"median":-6.974676,"eighty":-5.98699,"marketCap":1389255588},{"date":"2026-07-02","current":-7.092956,"twenty":-7.5092,"median":-6.96318,"eighty":-6.007936,"marketCap":1667476025},{"date":"2026-07-10","current":-8.059107,"twenty":-7.645417,"median":-7.006288,"eighty":-6.078901,"marketCap":1894607311},{"date":"2026-07-17","current":-7.917719,"twenty":-7.67473,"median":-7.092956,"eighty":-6.150138,"marketCap":1861368586},{"date":"2026-07-24","current":-7.637561,"twenty":-7.776537,"median":-7.12986,"eighty":-6.183485,"marketCap":1795506668},{"date":"2026-07-31","current":-7.648035,"twenty":-7.738833,"median":-7.190209,"eighty":-6.195797,"marketCap":1797968796},{"date":"2026-08-07","current":-7.82346,"twenty":-7.815082,"median":-7.208161,"eighty":-6.219919,"marketCap":1839209436},{"date":"2026-08-14","current":-7.218207,"twenty":-7.815082,"median":-7.209243,"eighty":-6.276357,"marketCap":1897132498},{"date":"2026-08-21","current":-7.119553,"twenty":-7.785196,"median":-7.218207,"eighty":-6.321676,"marketCap":1871203580},{"date":"2026-08-28","current":-7.187671,"twenty":-7.738833,"median":-7.209243,"eighty":-6.354091,"marketCap":1889106881},{"date":"2026-09-04","current":-6.576954,"twenty":-7.707949,"median":-7.198831,"eighty":-6.380999,"marketCap":1728594532},{"date":"2026-09-11","current":-6.30448,"twenty":-7.706597,"median":-7.187671,"eighty":-6.346489,"marketCap":1656981329},{"date":"2026-09-18","current":-5.350822,"twenty":-7.698741,"median":-7.142724,"eighty":-6.305624,"marketCap":1406335122},{"date":"2026-09-25","current":-4.761245,"twenty":-7.679328,"median":-7.119553,"eighty":-6.175428,"marketCap":1251378970},{"date":"2026-10-01","current":-4.998485,"twenty":-7.670132,"median":-7.112617,"eighty":-6.008983,"marketCap":1313731844}],"updateTime":1790993318463},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"DMRA\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2657523027","title":"Damora Therapeutics Begins Trial of DMR-001 in ET, Myelofibrosis","url":"https://stock-news.laohu8.com/highlight/detail?id=2657523027","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657523027?lang=en_us&edition=fundamental","pubTime":"2026-08-05 22:42","pubTimestamp":1785940975,"startTime":"0","endTime":"0","summary":"Damora Therapeutics  said Wednesday it initiated a global Phase 1/1b clinical trial of DMR-001 in patients with mutant calreticulin-driven essential thrombocythemia and myelofibrosis.The open-label, multicenter CLARITY-101 study will evaluate the safety, tolerability and preliminary efficacy of the investigational monoclonal antibody therapy.The dose-escalation portion will begin with a 100-milligram monthly subcutaneous dose and is designed to identify a recommended dose for further development.A planned expansion phase will assess DMR-001 in additional patient groups, earlier treatment settings and combinations with other therapies.Damora expects to report initial trial data beginning in mid-2027, the biotechnology company said.Price: 30.84, Change: +0.82, Percent Change: +2.71","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4144","EIPI","ET","EMLP","MLPA","MDST","BK4139","BK4539","BK4561","BK4106","BK4581","DMRA","TNGY","BK4007","AMZA","LENZ","AMLP","XELA","USAI","BK4226","UMI","BK4588","BK4585","TPZ","BK4590","ENFR","EIPX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657541907","title":"Damora Therapeutics Initiates Phase 1/1B Clarity-101 Clinical Trial of Dmr-001 in Patients with Mutant Calreticulin-Driven Essential Thrombocythemia and Myelofibrosis","url":"https://stock-news.laohu8.com/highlight/detail?id=2657541907","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657541907?lang=en_us&edition=fundamental","pubTime":"2026-08-05 20:00","pubTimestamp":1785931203,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nTUA5SFKJR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["DMRA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657541410","title":"Damora Therapeutics - Expects Initial Clarity-101 Trial Data Beginning Mid-2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2657541410","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657541410?lang=en_us&edition=fundamental","pubTime":"2026-08-05 20:00","pubTimestamp":1785931203,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nTUA5SFKJR:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","DMRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656309754","title":"Damora Therapeutics Grants 451,000 Inducement Stock Options at $28.99 Per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2656309754","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656309754?lang=en_us&edition=fundamental","pubTime":"2026-08-04 04:01","pubTimestamp":1785787275,"startTime":"0","endTime":"0","summary":"Damora Therapeutics grants 451,000 inducement stock options at $28.99 per shareDamora Therapeutics granted inducement stock options covering 451,000 ordinary shares to six newly hired, non-executive e","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nNDL5Cvm7d:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B64PRP62.GBP","LU2095319765.USD","SG9999014039.USD","SG9999014021.USD","BK4585","LU2210150020.SGD","IE00BN0W2T93.GBP","IE00BGHQF748.EUR","BK4112","BK4139","IE00B3QW5Z07.USD","IE00BN0W2W23.USD","IE00BKPKM429.USD","LU2210149790.SGD","SG9999014013.SGD","BK4588","LU0314104364.USD","BCDF","SG9999014005.SGD","IE00BN0W2V16.EUR","DMRA","NDAQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656309788","title":"Damora Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2656309788","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656309788?lang=en_us&edition=fundamental","pubTime":"2026-08-04 04:01","pubTimestamp":1785787260,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nTUA210CXG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","DMRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656307898","title":"Damora Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2656307898","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656307898?lang=en_us&edition=fundamental","pubTime":"2026-08-04 04:01","pubTimestamp":1785787260,"startTime":"0","endTime":"0","summary":"BOSTON, Aug.  03, 2026  (GLOBE NEWSWIRE) -- Damora Therapeutics, Inc. (NASDAQ: DMRA) (“Damora”), a biotechnology company working to fundamentally redefine care for patients with blood disorders, today","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/03/3337851/0/en/Damora-Therapeutics-Announces-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4007","LCLG","LENZ","BK4139","DMRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654701327","title":"U.S. Research ROUNDUP-Blackstone, Hartford Insurance, Zevra Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2654701327","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654701327?lang=en_us&edition=fundamental","pubTime":"2026-07-27 16:55","pubTimestamp":1785142545,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-Blackstone, Hartford Insurance, Zevra TherapeuticsJuly 27 (Reuters)-Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, incl","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260727:nL4N43T0K1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FMBH","AAPL","FCNCA","FUTY","CLF","CELC","AGIO","DLR","AXP","AALG","VGSR","TRUU","BAM","REET","CUBI","FLG","CDRE","DMRA","REAI","ARLO","BX","CIBR","CPF","CEG","FRBA","EBC","AAL","AMAL","HIG","BANR","AXPG","GM","HWM","SRCE","CATY","FHB","CYH","F","FTAI","FTNT","BAX","HON","AAPW","FVCB","AAPB","BWXT","BAH","BY","CHTR","FISI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654949000","title":"Damora Therapeutics Inc (pre-reincorporation) : Jefferies Initiates Coverage with Buy Rating; Price Target $50","url":"https://stock-news.laohu8.com/highlight/detail?id=2654949000","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654949000?lang=en_us&edition=fundamental","pubTime":"2026-07-27 14:02","pubTimestamp":1785132174,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260727:nFWN43T0JL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","DMRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654062708","title":"Damora Therapeutics initiated with a Buy at Jefferies","url":"https://stock-news.laohu8.com/highlight/detail?id=2654062708","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654062708?lang=en_us&edition=fundamental","pubTime":"2026-07-27 05:20","pubTimestamp":1785100813,"startTime":"0","endTime":"0","summary":"Jefferies initiated coverage of Damora Therapeutics (DMRA) with a Buy rating and $50 price target. The company’s lead asset DMR-001 is a half-life ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/damora-therapeutics-initiated-with-a-buy-at-jefferies-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/damora-therapeutics-initiated-with-a-buy-at-jefferies-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4226","LENZ","BK4007","XELA","BK4139","BK4539","BK4106","DMRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652668288","title":"Damora Therapeutics Redomiciles from Delaware to Cayman Islands","url":"https://stock-news.laohu8.com/highlight/detail?id=2652668288","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652668288?lang=en_us&edition=fundamental","pubTime":"2026-07-17 20:02","pubTimestamp":1784289738,"startTime":"0","endTime":"0","summary":"Damora Therapeutics redomiciles from Delaware to Cayman IslandsDamora Therapeutics completed a redomestication to the Cayman Islands from Delaware, effective July 16, 2026.Each Delaware common share c","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260717:nNDL66QBHT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NDAQ","SG9999014013.SGD","SG9999014039.USD","SG9999014021.USD","IE00BKPKM429.USD","DMRA","LU2095319765.USD","IE00BGHQF748.EUR","BK4585","BK4139","LU2210150020.SGD","BK4112","BCDF","IE00B3QW5Z07.USD","BK4588","IE00B64PRP62.GBP","IE00BN0W2W23.USD","IE00BN0W2T93.GBP","IE00BN0W2V16.EUR","SG9999014005.SGD","LU0314104364.USD","LU2210149790.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649609858","title":"Damora Therapeutics (DMRA) Joins Russell Indexes With Valuation Still Looking About Right","url":"https://stock-news.laohu8.com/highlight/detail?id=2649609858","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649609858?lang=en_us&edition=fundamental","pubTime":"2026-07-07 11:32","pubTimestamp":1783395154,"startTime":"0","endTime":"0","summary":"Damora Therapeutics (DMRA) has been added to a wide range of Russell indices, including the Russell 2000, 2500 and 3000 families. This change can influence institutional demand and trading activity.\nSee our latest analysis for Damora Therapeutics.\nDamora Therapeutics' recent additions to multiple Russell indices come alongside strong recent share price momentum, with a 7 day share price return of 23.09% and a 30 day share price return of 41.84%. However, the 5 year total shareholder return is...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-dmra/damora-therapeutics/news/damora-therapeutics-dmra-joins-russell-indexes-with-valuatio","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-dmra/damora-therapeutics/news/damora-therapeutics-dmra-joins-russell-indexes-with-valuatio","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LENZ","BK4539","BK4139","DMRA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648251695","title":"Damora Therapeutics Grants Inducement Stock Options for 453,500 Shares at USD 26.01 Each","url":"https://stock-news.laohu8.com/highlight/detail?id=2648251695","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648251695?lang=en_us&edition=fundamental","pubTime":"2026-07-02 04:01","pubTimestamp":1782936076,"startTime":"0","endTime":"0","summary":"Damora Therapeutics grants inducement stock options for 453,500 shares at USD 26.01 eachDamora Therapeutics granted inducement stock options to nine newly hired, non-executive employees on July 1, 202","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260701:nNDL5PShfg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B64PRP62.GBP","IE00BN0W2V16.EUR","NDAQ","IE00BGHQF748.EUR","IE00BN0W2T93.GBP","IE00BKPKM429.USD","BK4585","BK4139","SG9999014021.USD","LU2095319765.USD","SG9999014013.SGD","IE00BN0W2W23.USD","DMRA","LU0314104364.USD","LU2210149790.SGD","BK4112","BK4588","IE00B3QW5Z07.USD","SG9999014005.SGD","SG9999014039.USD","LU2210150020.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648525197","title":"Damora Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2648525197","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648525197?lang=en_us&edition=fundamental","pubTime":"2026-07-02 04:01","pubTimestamp":1782936060,"startTime":"0","endTime":"0","summary":"BOSTON, July  01, 2026  (GLOBE NEWSWIRE) -- Damora Therapeutics, Inc. (NASDAQ: DMRA) (“Damora”), a biotechnology company working to fundamentally redefine care for patients with blood disorders, today","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/07/01/3320969/0/en/Damora-Therapeutics-Announces-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","DMRA","LENZ","BK4007","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645026491","title":"Analysts Have Conflicting Sentiments on These Healthcare Companies: Damora Therapeutics (DMRA), Summit Therapeutics (SMMT) and Elicio Therapeutics (ELTX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2645026491","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645026491?lang=en_us&edition=fundamental","pubTime":"2026-06-22 18:33","pubTimestamp":1782124427,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Damora Therapeutics (DMRA), Summit Therapeutics (S...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-damora-therapeutics-dmra-summit-therapeutics-smmt-and-elicio-therapeutics-eltx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-damora-therapeutics-dmra-summit-therapeutics-smmt-and-elicio-therapeutics-eltx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","HCSG","BK4588","BK4139","DMRA","BK4137","LABU","BK4581","BK4007","LU2488822045.USD","ELTX","LU0029874061.USD","LU0128526141.USD","XLV","XBI","SMMT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644296287","title":"Damora Therapeutics shareholders elect Landsittel, Turtle to board","url":"https://stock-news.laohu8.com/highlight/detail?id=2644296287","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644296287?lang=en_us&edition=fundamental","pubTime":"2026-06-18 04:01","pubTimestamp":1781726460,"startTime":"0","endTime":"0","summary":"Damora Therapeutics held its annual stockholder meeting on June 17, 2026.Stockholders backed the board’s two director nominees, clearing their continued service through the 2029 annual meeting.Investors also endorsed an annual cadence for future advisory votes on executive pay; the board plans to hold those votes yearly.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Damora Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 17, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260617:nNDL1W9XC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","DMRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642575295","title":"Analysts Offer Insights on Healthcare Companies: Phibro Animal Health (PAHC) and Damora Therapeutics (DMRA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2642575295","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642575295?lang=en_us&edition=fundamental","pubTime":"2026-06-12 21:10","pubTimestamp":1781269838,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Phibro Animal Health (PAHC) and Damora Therapeutics ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-phibro-animal-health-pahc-and-damora-therapeutics-dmra-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-phibro-animal-health-pahc-and-damora-therapeutics-dmra-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XLV","PAHC","BK4137","BK4585","XBI","BK4581","BK4588","LENZ","HCSG","LU0029874061.USD","LU0128526141.USD","BK4007","BK4139","BK4539","DMRA","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642094281","title":"Damora Therapeutics publishes DMR-001 mutant calreticulin antibody presentation","url":"https://stock-news.laohu8.com/highlight/detail?id=2642094281","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642094281?lang=en_us&edition=fundamental","pubTime":"2026-06-11 20:17","pubTimestamp":1781180279,"startTime":"0","endTime":"0","summary":"Damora Therapeutics published a preclinical research presentation on DMR-001, an Fc-null, half-life optimized monoclonal antibody targeting mutant calreticulin in ET and MF.Program highlights included binding affinity of 0.074 nM for Type 1 del52 mutCALR, 0.31 nM for Type 2 ins5.Non-human primate PK half-life was 15 days, versus 3.1 days for a reference mutCALR antibody; expected Phase 1 dosing SC Q4W.Data showed internalization of surface mutCALR, inhibition of pSTAT1 signaling, reduced proliferation; no ADCC or CDC activity reported.A Phase 1/1b study in mutCALR-driven MPN patients is planned to initiate in Q3 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Damora Therapeutics Inc. published the original content used to generate","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260611:nNDL2jL0Yl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","DMRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642283756","title":"Damora Therapeutics Inc : H.c. Wainwright Initiates Coverage With Buy Rating; Price Target $45","url":"https://stock-news.laohu8.com/highlight/detail?id=2642283756","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642283756?lang=en_us&edition=fundamental","pubTime":"2026-06-11 18:09","pubTimestamp":1781172549,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260611:nFWN42J0AC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","DMRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642402160","title":"U.S. RESEARCH ROUNDUP-Arthur J. Gallagher & Co, Datadog, Oracle","url":"https://stock-news.laohu8.com/highlight/detail?id=2642402160","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642402160?lang=en_us&edition=fundamental","pubTime":"2026-06-11 15:59","pubTimestamp":1781164792,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-Arthur J. Gallagher & Co, Datadog, Oracle June 11 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260611:nL4N42J0KA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTBI","GNRC","AXSM","BBYY","AMDW","ORCX","CTVA","AMDG","CRBG","DMRA","AMDD","BABO","WMS","AMAT","HSIC","BABA","GEV","CHWY","GEVX","CGEM","NRGV","FE","INTC","NETG","HUMA","INSM","AMDY","CPT","CITR","EXTR","HNGE","EQH","CASY","HIG","KBAB","GKOS","GD","AJG","AMD","FSLR","INCY","NET","CLOV","ASO","NVST","AGIO","ORCL","DDOG","ORCS","BKH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641027483","title":"TD Cowen Initiates Damora Therapeutics at Buy","url":"https://stock-news.laohu8.com/highlight/detail?id=2641027483","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641027483?lang=en_us&edition=fundamental","pubTime":"2026-06-08 18:20","pubTimestamp":1780914031,"startTime":"0","endTime":"0","summary":"Damora Therapeutics (DMRA) has an average rating of buy and mean price target of 43.14, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LENZ","TD","BK4539","DMRA","BK4585","COWN","BK4566","BK4007","BK4139","BK4127","BK4207"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":2,"totalSize":68,"code":"91000000","status":"200"}]}}